News NICE backs digital technologies for COPD rehab More patients in England with chronic obstructive pulmonary disease (COPD) could soon be able to access rehabilitation programmes, after cost-effectiveness watchdog NICE b
Views & Analysis Digital Health Round-up: Fitbit falters, NHS picks six winne... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face